These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10652038)

  • 1. Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia.
    Wuermser LA; Reilly C; Poindexter JR; Sakhaee K; Pak CY
    Kidney Int; 2000 Feb; 57(2):607-12. PubMed ID: 10652038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Wuermser LA; Poindexter J; Pak CY
    J Clin Pharmacol; 1998 Nov; 38(11):1035-41. PubMed ID: 9824785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of varying doses of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Gonzalez G; Taylor R; Wuermser LA; Pak CY
    Am J Ther; 1999 Jan; 6(1):45-50. PubMed ID: 10423646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.
    Ruml LA; Pak CY
    Am J Kidney Dis; 1999 Jul; 34(1):107-13. PubMed ID: 10401023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
    Odvina CV; Mason RP; Pak CY
    Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion.
    Frassetto LA; Nash E; Morris RC; Sebastian A
    Kidney Int; 2000 Aug; 58(2):748-52. PubMed ID: 10916098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials.
    Pak CY
    Clin Nephrol; 2000 Oct; 54(4):271-5. PubMed ID: 11076102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis.
    Odvina CV; Preminger GM; Lindberg JS; Moe OW; Pak CY
    Kidney Int; 2003 Jan; 63(1):240-7. PubMed ID: 12472789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
    Koenig K; Padalino P; Alexandrides G; Pak CY
    J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects.
    Vongpatanasin W; Peri-Okonny P; Velasco A; Arbique D; Wang Z; Ravikumar P; Adams-Huet B; Moe OW; Pak CYC
    Am J Cardiol; 2016 Sep; 118(6):849-853. PubMed ID: 27448942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazide diuretics, hypokalemia and cardiac arrhythmias.
    Hollifield JW; Slaton PE
    Acta Med Scand Suppl; 1981; 647():67-73. PubMed ID: 6942642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium Magnesium Citrate Is Superior to Potassium Chloride in Reversing Metabolic Side Effects of Chlorthalidone.
    Vongpatanasin W; Giacona JM; Pittman D; Murillo A; Khan G; Wang J; Johnson T; Ren J; Moe OW; Pak CCY
    Hypertension; 2023 Dec; 80(12):2611-2620. PubMed ID: 37846572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical action of potassium-magnesium citrate in nephrolithiasis.
    Pak CY; Koenig K; Khan R; Haynes S; Padalino P
    J Bone Miner Res; 1992 Mar; 7(3):281-5. PubMed ID: 1585829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.
    Papademetriou V; Burris J; Kukich S; Freis ED
    Arch Intern Med; 1985 Nov; 145(11):1986-90. PubMed ID: 3904654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of potassium-magnesium citrate on upper gastrointestinal mucosa.
    Gonzalez GB; Pak CY; Adams-Huet B; Taylor R; Bilhartz LE
    Aliment Pharmacol Ther; 1998 Jan; 12(1):105-10. PubMed ID: 9692708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of various potassium salts on renal citrate excretion.
    Sakhaee K; Alpern R; Jacobson HR; Pak CY
    J Clin Endocrinol Metab; 1991 Feb; 72(2):396-400. PubMed ID: 1899422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
    Kohvakka A
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.